RSS
4 Jan 2021

Protalix BioTherapeutics to Participate in Upcoming Investor Conferences in January

Author: admintech | Filed under: Press Release

CARMIEL, Israel, Jan. 4, 2021 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…

This entry was posted on Monday, January 4th, 2021 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»